The Global Biopharma Plastics Market is expected to exhibit a strong performance in 2023, with a total value of
Looking ahead, the market is anticipated to maintain robust growth, with an expected
for the forecast period (2023-2032). This growth is driven by various factors, such as the continuous rise in worldwide healthcare spending & the growing prevalence of cancer problems globally. As healthcare centers & technologies develop, the desire for better-quality biopharma plastic equipment & parts is anticipated to rise, fueling market expansion in the upcoming years.
Biopharma plastics provide numerous advantages, making them the perfect choice for several healthcare uses. Their low chemical reactivity, high resistivity, & good thermal stability make them the preferred materials for the production of products such as containers, syringes, bioreactor bags & disposable connectors. These polymers’ versatility & their ability to serve different needs in the healthcare industry have resulted in their enhanced adoption, further boosting the biopharma plastics market.
Market Dynamic
Key polymer types, such as PE (polyethylene), PVC (polyvinyl chloride), PP (polypropylene), ABS (acrylonitrile butadiene styrene), & PET (Polyethylene Terephthalate), have experienced rising interest within the biopharmaceutical sector. This demand is expected to continue as the biopharmaceutical sector develops & looks for advanced solutions for medical & healthcare equipment. Biopharma plastics help in the development of reliable, durable, & economically viable products, which are important features in the medical field. North America played an important role in the biopharma plastics market, with the U.S. leading this market. The region is anticipated to witness substantial growth due to the adoption of several initiatives like the Medicaid & ACA (Affordable Care Act) have expanded the scope of healthcare services to more people, escalating the demand for medical devices, branded drugs, & medical facilities. This, in turn, spurs the consumption of biopharma plastics, especially in the production of disposable syringes, medical connectors, depth filters, & several other pivotal medical parts.
Breast cancer ranks as the most common cancer affecting women in the United States, especially elderly & middle-aged people. Hormone therapy for menopausal symptoms has been marked as a significant contributing factor to cases of breast cancer. As mastectomy remains a common treatment for breast cancer, the demand for biopharma plastic-based items such as valves, syringes, & medical disposable connectors, is anticipated to rise. This trend is set to contribute to the growth of the market of biopharma plastics in the United States for the forecast period, reinforcing the industry's positive outlook. Overall, the biopharma plastics market is poised for continued expansion, driven by technological advancements, increasing healthcare spending, and the demand for innovative medical solutions.
Research Scope and Analysis
By Polymer Type
The global biopharma plastics market is dominated by PVC (Polyvinyl chloride), which accounted for the maximum share in 2023. Polyvinyl chloride’s widespread usage can be attributed to its capability to undergo several processes without cracking or breaking, making it more versatile in several applications. Its exceptional resistance, flexibility, & ability to resist higher temperatures make it the most preferred choice for manufacturing disposable connectors, syringes, depth filters, & other biopharma plastic applications. Biopharmaceutical plastic polymers have gained significant popularity due to their capacity to provide a sleek, long-lasting surface that is resistant to UV & chemical exposure. These polymers also show remarkable resistance to oxidation, together with water repellency & vapor permeability, leading to the creation of robust, eco-friendly, & economical final items. Biopharmaceutical plastic materials, which naturally repel water, are now being used in healthcare for protective clothing.
Furthermore, Large manufacturing facilities & a robust industry are driving this growth. Additionally, plastics like polytetrafluoroethylene & polyethylene are famous due to their appearance, durability, & resistance to cleaning agents, further leading to market expansion in the upcoming future.
By Application
Syringes dominate the biopharma plastics market, accounting for the maximum share in 2023. The prefilled syringes market is anticipated to observe significant growth because of several factors like their cost-effectiveness, convenience, low injection errors, minimal microbial contamination, & dilution errors, leading to enhanced demand.
The growth of this segment can be credited to the rising acceptance of developed technologies for healthcare & medicine, the increasing production of large molecules, & the increasing spending in such advanced healthcare facilities. One-time-use biopharma plastic syringes provide ease of use & convenience, leading to their enhanced popularity in the market. Moreover, the existence of properly developed healthcare infrastructure in different nations further escalates the demand for these devices, consequently boosting the need for biopharma plastics utilized in their manufacturing. The continuous rise in demand for prefilled syringes, driven by their usage convenience, and cost-effectiveness, is expected to positively impact the growth of the syringes segment in the biopharma plastics sector for the period (2023-2032).
The Global Biopharma Plastics Market Report is segmented on the basis of the following:
By Polymer Type
• Polyethylene (PE)
• Polypropylene (PP)
• Polyethylene Terephthalate (PET)
• Polyvinyl Chloride (PVC)
• Acrylonitrile Butadiene Styrene (ABS)
• Polycarbonate (PC)
• Others
By Application
• Containers
• Bioreactor Bags
• Protective Wear
• Depth Filters
• Syringes
• Disposable Medical Connectors
• Others
Regional Analysis
The Asia Pacific region emerges as the dominant market for biopharma plastics, with a maximum share of 31.1% of total revenue, in 2023. In Asia-Pacific, China led the biopharma plastics market. The rising demand for better quality biopharma plastic equipment & components from hospitals in emerging economies such as India, China, & Japan, driven by their increasing population & healthcare spending, has been an important factor propelling the market growth in this region.
Meanwhile, North America is anticipated to witness a high CAGR in terms of revenue in the foreseeable future. This growth is accredited to the robust medical sector in the area, especially in the United States which has been a major driver for the demand for biopharma plastics. The existence of major biopharma plastic manufacturers like Eastman Chemical Co., Celanese Corporation, & DuPont in the U.S. has also played a vital role in propelling the market forward in the nation.
By Region
North America
• The U.S.
• Canada
Europe
• Germany
• The U.K.
• France
• Italy
• Russia
• Spain
• Benelux
• Nordic
• Rest of Europe
Asia-Pacific
• China
• Japan
• South Korea
• India
• ANZ
• ASEAN
• Rest of Asia-Pacific
Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of Latin America
Middle East & Africa
• Saudi Arabia
• UAE
• South Africa
• Israel
• Egypt
• Rest of MEA
Competitive Landscape
The market for biopharma plastics is characterized by the presence of prominent players, alongside a few medium and small regional companies. These major players are actively engaged in developing advanced polymers to cater to the increasing demand for biopharma plastic components from the healthcare sector.
The global biopharma plastics industry is known for its intense competition, primarily driven by the concentrated presence of major companies across different regions. These companies fiercely compete with each other and frequently engage in activities such as acquisitions, mergers, and collaborations. As an example, in April 2023, PSG Group International, a leading global provider of pump, metering, and dispensing solutions, introduced a new biotech brand named 'PSG® Biotech for Life Science and Biopharma.'
Some of the prominent players in the Global Biopharma Plastics Market are:
• SABIC
• BASF SE
• LG Chem
• Solvay
• Toray Industries, Inc.
• Dow, Inc.
• INEOS Group
• Tekni-Plex
• Formosa Plastics Corporation
• Covestro AG
• CHIMEI
• Other Key Players
COVID-19 Pandemic & Recession: Impact on the Global Biopharma Plastics Market:
The COVID-19 pandemic and the subsequent global recession have significantly impacted the biopharma plastics market. During the pandemic, the healthcare industry witnessed unprecedented challenges and an urgent need for medical supplies and equipment, including biopharma plastic components. The increased demand for personal protective equipment (PPE), medical devices, and vaccine-related products put immense pressure on the biopharma plastics market. However, disruptions in supply chains, manufacturing facilities, and logistics due to lockdowns and restrictions hampered production and distribution, leading to shortages and delays in the availability of essential products.
Furthermore, the economic downturn caused by the pandemic and recession affected investment and funding in the biopharma sector. Many companies faced financial constraints, leading to a slowdown in research and development activities related to innovative biopharma plastics. Additionally, some organizations shifted their priorities towards the development of COVID-19 treatments and vaccines, diverting resources from other areas of healthcare. Despite these challenges, the pandemic also highlighted the importance of resilient and sustainable supply chains, prompting the industry to explore new avenues for collaboration and innovation in biopharma plastics production to meet future healthcare demands.
Report Characteristics |
Market Size (2023) |
USD 5695.3 Mn |
Forecast Value (2032) |
USD 16243.4 Mn |
CAGR (2023-2032) |
12.4% |
Historical Data |
2017 - 2022 |
Forecast Data |
2023 - 2032 |
Base Year |
2022 |
Estimate Year |
2023 |
Report Coverage |
Market Revenue Estimation, Market Dynamics, Competitive Landscape, Growth Factors and etc. |
Segments Covered |
By Polymer Type (Polyethylene, Polypropylene,
Polyethylene Terephthalate, Polyvinyl Chloride,
Acrylonitrile Butadiene Styrene, Polycarbonate,
Polytetrafluoroethylene, and Others), and By
Application (Containers, Bioreactor bags, protective
wear, Depth Filters, Syringes, Disposable Medical
Connectors, and Others). |
Regional Coverage |
North America – The US and Canada; Europe – Germany, The UK, France, Russia, Spain, Italy, Benelux, Nordic, & Rest of Europe; Asia- Pacific– China, Japan, South Korea, India, ANZ, ASEAN, Rest of APAC; Latin America – Brazil, Mexico, Argentina, Colombia, Rest of Latin America; Middle East & Africa – Saudi Arabia, UAE, South Africa, Turkey, Egypt, Israel, & Rest of MEA
|
Prominent Players |
SABIC, BASF SE, LG Chem, Solvay, Toray Industries,
Inc., Dow, Inc., INEOS Group, Tekni-Plex, Formosa
Plastics Corporation, Covestro AG, CHIMEI, and Other
Key Players. |
Purchase Options |
We have three licenses to opt for: Single User License (Limited to 1 user), Multi-User License (Up to 5 Users), and Corporate Use License (Unlimited User) along with free report customization equivalent to 0 analyst working days, 3 analysts working days and 5 analysts working days respectively. |